ArticleObesity surgery2026
Influence of Heart Function on the Assessment of MASLD Using Indocyanine Green Clearance.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe incidence of MASLD is rapidly increasing while the accuracy of noninvasive tests for MASLD remains limited. Indocyanine green clearance is a dynamic liver function test established for the evaluation of liver disease but is limited by the major influence of systemic circulation. We aimed to assess the role of Indocyanine green clearance in the evaluation of MASLD, together with cardiac function measurements.
methodsWe conducted a prospective controlled study of 77 patients who underwent metabolic and bariatric surgery (MBS) and 25 controls who underwent elective cholecystectomy. Indocyanine green clearance was measured and interpreted as plasma disappearance rate (PDR) and residual dose at 15 min (R15). Wedge liver biopsies were obtained during MBS and assessed using the Kleiner classification. In the observed group cardiac output and cardiac index were measured and used to evaluate the influence of cardiac function on liver function monitoring.
resultsIndocyanine green clearance was significantly lower in the observed patients compared to controls (p < 0.05). PDR was significantly associated with a pathological histological score (p = 0.03). Cardiac output and cardiac index were independently associated with R15 (p < 0.01). PDR adjusted for cardiac output and cardiac index significantly corelated with liver fibrosis, revealing a relationship not evident in unadjusted measurements.
conclusionsIndocyanine green clearance reflects MASLD severity in MBS patients. Its diagnostic value is further enhanced by adjusting for cardiac function. This novel combined approach may improve noninvasive assessment of MASLD and support treatment individualization in patients preparing for MBS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.